CURRENTLY AVAILABLE NONINVASIVE TESTS ACCURATELY STAGE FIBROSIS IN PATIENTS WITH NONALCOHOLIC STEATOHEPATITIS (NASH)

被引:0
|
作者
Harrison, Stephen A. [1 ]
Lawitz, Eric J. [2 ]
Wong, Vincent Wai-Sun [3 ]
Anstee, Quentin M. [4 ]
Trauner, Michael H. [5 ]
Romero-Gomez, Manuel [6 ]
Bhandari, Bal [7 ]
Abdelmalek, Manal F. [8 ]
Sanyal, Arun J. [9 ]
Patel, Keyur [10 ]
Leroy, Vincent [11 ]
Bureau, Christophe [12 ]
Sasso, Magali [13 ]
Fournier, Celine D. [13 ]
Sandrin, Laurent [13 ]
Han, Ling [14 ]
Li, Georgia [14 ]
Kersey, Kathryn [14 ]
Camargo, Marianne [14 ]
Djedjos, Stephen [14 ]
Myers, Robert P. [14 ]
Goodman, Zackary [15 ]
Younossi, Youssef [16 ]
机构
[1] Pinnacle Clin Res, San Antonio, TX USA
[2] Univ Texas Hlth San Antonio, Texas Liver Inst, San Antonio, TX USA
[3] Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Peoples R China
[4] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne, Tyne & Wear, England
[5] Med Univ Vienna, Div Gastroenterol & Hepatol, Vienna, Austria
[6] Univ Seville, Virgen Del Rocio Univ Hosp, Digest Dis Dept, Ciberehd,Seliver Grp,IBIS, Seville, Spain
[7] Delta Res Partners, Bastrop, LA USA
[8] Duke Univ, Durham, NC 27706 USA
[9] Virginia Commonwealth Univ, Richmond, VA 23284 USA
[10] Univ Hlth Network, Toronto, ON, Canada
[11] Grenoble Univ Hosp, Hepatol Dept, Grenoble, France
[12] CHU Toulouse, Toulouse, France
[13] Echosens, Paris, France
[14] Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA
[15] Inova Fairfax Hosp, Falls Church, VA USA
[16] Inova Hlth Syst, Falls Church, VA USA
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
2295
引用
收藏
页码:1349A / 1350A
页数:2
相关论文
共 50 条
  • [1] A STEPWISE SCREENING APPROACH USING NONINVASIVE TESTS TO IDENTIFY PHENOTYPIC NONALCOHOLIC STEATOHEPATITIS (NASH) PATIENTS WITH FIBROSIS FOR CLINICAL TRIALS
    Loomba, Rohit
    Noureddin, Mazen
    Lawitz, Eric
    Kowdley, Kris V.
    Lee, Lois
    Schlegel, Amnon
    Graham, Hiba
    Zhang, Lu
    Russell, Kerry
    Alkhouri, Naim
    HEPATOLOGY, 2023, 78 : S1186 - S1189
  • [2] Noninvasive evaluation of nonalcoholic steatohepatitis (NASH)
    Mansour-Ghanaei, Fariborz
    Vahhabi-Moghaddam, Masrour
    Joukar, Farahnaz
    Asgharnezhad, Mehrnaz
    Kiyani, Noufar
    CASPIAN JOURNAL OF INTERNAL MEDICINE, 2013, 4 (04) : 797 - 798
  • [3] Predictors of fibrosis in nonalcoholic steatohepatitis (NASH)
    Copaci, I
    Micu, L
    Cojocaru, L
    Voiculescu, M
    JOURNAL OF HEPATOLOGY, 2003, 38 : 192 - 192
  • [4] Advanced Fibrosis Based on Noninvasive Tests in Nonalcoholic Steatohepatitis (NASH) Is Associated with Impairment of Patient-Reported Outcomes
    Younossi, Zobair M.
    Stepanova, Maria
    Anstee, Quentin M.
    Lawitz, Eric J.
    Wong, Vincent Wai Sun
    Romero-Gomez, Manuel
    Kersey, Kathryn
    Li, Georgia
    Subramanian, Mani
    Myers, Robert P.
    Djedjos, Stephen
    Okanoue, Takeshi
    Trauner, Michael H.
    Harrison, Stephen A.
    Goodman, Zachary D.
    HEPATOLOGY, 2018, 68 : 1134A - 1135A
  • [5] Noninvasive predictors for liver fibrosis in patients with nonalcoholic steatohepatitis
    Hüseyin Saadettin Uslusoy
    Selim Giray Nak
    Macit Gülten
    World Journal of Hepatology, 2011, 3 (08) : 219 - 227
  • [6] Noninvasive predictors for liver fibrosis in patients with nonalcoholic steatohepatitis
    Uslusoy, Hiseyin Saadettin
    Nak, Selim Giray
    Gulten, Macit
    WORLD JOURNAL OF HEPATOLOGY, 2011, 3 (08) : 219 - 227
  • [7] VALIDATION OF HISTOLOGIC AND NONINVASIVE MEASURES OF FIBROSIS AS SURROGATE ENDPOINTS OF DISEASE PROGRESSION IN PATIENTS WITH NONALCOHOLIC STEATOHEPATITIS (NASH)
    Anstee, Quentin M.
    Trauner, Michael H.
    Lawitz, Eric J.
    Bzowej, Natalia
    Vuppalanchi, Raj
    Younes, Ziad
    Ding, Dora
    Li, Georgia
    Kersey, Kathryn
    Camargo, Marianne
    Djedjos, Stephen
    Subramanian, Mani
    Myers, Robert P.
    Wong, Vincent Wai-Sun
    Harrison, Stephen A.
    Okanoue, Takeshi
    Romero-Gomez, Manuel
    Goodman, Zackary
    HEPATOLOGY, 2019, 70 : 1342A - 1343A
  • [8] RACE DOES NOT AFFECT THE PERFORMANCE OF ROUTINELY AVAILABLE NONINVASIVE TESTS FOR THE DISCRIMINATION OF ADVANCED FIBROSIS DUE TO NONALCOHOLIC STEATOHEPATITIS (NASH) IN THE PHASE 3 STELLAR TRIALS OF SELONSERTIB
    Wong, Vincent Wai-Sun
    Tak, Won Young
    Goh, George Boon Bee
    Cheng, Pin-Nan
    Lawitz, Eric J.
    Younossi, Zobair M.
    Vuppalanchi, Raj
    Bzowej, Natalie H.
    Younes, Ziad
    Alkhouri, Naim
    Wang, Ya
    Kersey, Kathryn
    Li, Georgia
    Camargo, Marianne
    Myers, Robert P.
    Djedjos, C. Stephen
    Harrison, Stephen A.
    Goodman, Zachary D.
    Trauner, Michael H.
    Romero-Gomez, Manuel
    Anstee, Quentin M.
    Sarin, Shiv Kumar
    Nguyen, Mindie H.
    Okanoue, Takeshi
    HEPATOLOGY, 2019, 70 : 1029A - 1030A
  • [9] MACHINE LEARNING MODELS ACCURATELY INTERPRET LIVER HISTOLOGY IN PATIENTS WITH NONALCOHOLIC STEATOHEPATITIS (NASH)
    Pokkalla, Harsha
    Pethia, Kishalve
    Glass, Benjamin
    Kerner, Jennifer K.
    Gindin, Yevgeniy
    Han, Ling
    Huss, Ryan
    Chung, Chuhan
    Djedjos, Stephen
    Subramanian, Mani
    Myers, Robert P.
    Resnick, Murray
    Harrison, Stephen A.
    Goodman, Zachary D.
    Khosla, Aditya
    Beck, Andrew
    Wapinski, Ilan
    Younossi, Zobair M.
    HEPATOLOGY, 2019, 70 : 121A - 122A
  • [10] Systematic review of fibrosis progression in nonalcoholic steatohepatitis (NASH)
    Argo, Curtis K.
    Northup, Patrick G.
    Caldwell, Stephen H.
    HEPATOLOGY, 2006, 44 (04) : 650A - 651A